“…In this context, a variety of factors have been associated with an increased EIL rate; examples are—but not limited to—smoking, maxillary site, male gender, short implant length, implant type/brand, number of implants, immediate placement, need of bone grafting, non‐submerged healing, history of periodontitis, the clinician and specific medication intake (Alsaadi, Quirynen, Komárek, & van Steenberghe, ; Antoun, Karouni, Abitbol, Zouiten, & Jemt, ; Berglundh, Persson, & Klinge, ; Bryant, ; Chrcanovic, Kisch, Albrektsson, & Wennerberg, ; Derks et al, ; Esposito, Grusovin, Loli, Coulthard, & Worthington, ; Hickin, Shariff, Jennette, Finkelstein, & Papapanou, ; Jemt, ; Manzano et al, ; Olate, Lyrio, de Moraes, Mazzonetto, & Moreira, ; Olmedo‐Gaya, Manzano‐Moreno, Cañaveral‐Cavero, Dios Luna‐del Castillo, & Vallecillo‐Capilla, ; Palma‐Carrió, Maestre‐Ferrín, Peñarrocha‐Oltra, Peñarrocha‐Diago, & Peñarrocha‐Diago, ; Pommer et al, ; Troiano et al, ). For example, PPI (Al Subaie et al, ; Chrcanovic, Kisch, Albrektsson, & Wennerberg, ; Wu et al, ), SSRI (Wu et al, ) and antidepressants in general (Chrcanovic et al ), which are all rather common in the elderly, have been associated with an increased risk for implant failure.…”